MRUS
Merus BV
NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY
$90.00
+0.00% today
Updated 2025-12-30
Market cap
$6.83B
P/E ratio
—
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$33 – $97
Volume
1.3M
Merus BV (MRUS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-7.94%
ROE
-0.52%
ROA
-0.27%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $558000.00 | $-9.91M | -984.95% | -1,775.27% | -1,775.63% |
| 2014 | $1.30M | $-17.41M | -787.64% | -1,336.91% | -1,336.07% |
| 2015 | $1.91M | $-23.26M | -749.40% | -1,213.18% | -1,220.79% |
| 2016 | $2.51M | $-47.44M | -634.02% | -1,110.80% | -1,889.92% |
| 2017 | $21.91M | $-64.77M | -55.72% | -161.09% | -295.57% |
| 2018 | $33.50M | $-24.71M | -42.70% | -119.19% | -73.77% |
| 2019 | $27.76M | $-49.17M | -78.85% | -188.41% | -177.15% |
| 2020 | $24.51M | $-70.00M | -133.91% | -253.41% | -285.59% |
| 2021 | $43.15M | $-58.70M | -99.95% | -183.22% | -136.06% |
| 2022 | $38.84M | $-122.52M | 74.37% | -384.84% | -315.48% |
| 2023 | $39.81M | $-140.34M | 73.62% | -356.22% | -352.56% |
| 2024 | $34.88M | $-207.85M | 37.15% | -752.96% | -595.93% |